1 , 2 Since introduction of the model for end-stage liver disease (MELD) scoring system for organ allocation in liver transplant candidates in 2002, the incidence of renal dysfunction among liver transplant recipients has been significantly increasing, contributing to an increasing trend in simultaneous liver-kidney transplantation (SLK) after 2002. 3 – 5 AKI affects 25% to 50% of liver transplant recipients, while CKD develops in 30% to 90% and risk of end-stage renal disease (ESRD) requiring renal replacement therapy (RRT) is in the range of 2% to 5% per year after transplantation. 6 Native kidney function recovery following liver transplantation alone (LTA) is difficult to predict, and indications for SLK transplantation are not precisely defined.
1
—
—